| Patient | Johnny Cash |
|---|---|
| Date of birth | 1932-02-26 |
| Identifiers | MRN HR-ML004-SYN-TD; SSN (made up) 000-04-8125 |
| Document date | 2003-03-27 |
| Author | Ayesha Rahimi, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Type 2 diabetes above goal in a 71-year-old man with autonomic and peripheral neuropathy and orthostatic hypotension. Please confirm whether diabetic autonomic neuropathy explains his lightheadedness on standing, advise on treating it, and help choose add-on glucose-lowering therapy. [S]
Urgency: Routine, within four weeks; to coincide with his diabetes check. [S]
Questions for the consultant:
Mr. Cash is seen at the request of Dr. Hale, on the same day as his four-week diabetes check. Since the first visit he has taken metformin 1000 mg twice daily without stomach upset, and his fasting home glucose readings run 140 to 170 mg/dL, with none below 70 and no shakiness, sweating, or confusion. He stands up in stages, has raised the head of his bed, wears waist-high compression, and drinks about 2 liters a day. He is still lightheaded on standing most mornings and after meals, but he has had no further falls and no fainting. He has no nausea, diarrhea, early fullness, or difficulty passing urine. His feet are numb to the ankles, unchanged. He asks what is causing the lightheadedness. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
1 later historical claim is omitted because it describes events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 500 mg oral tablet, one tablet by mouth twice daily with meals | One tablet by mouth twice daily with meals | Oral route | 2001-05-06 to 2003-02-27 | completed | S |
| Metformin 1000 mg oral tablet, one tablet by mouth twice daily with meals | One tablet by mouth twice daily with meals | Oral route | 2003-02-27 | active | S |
| Sitagliptin 100 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2003-03-27 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2003-02-27 | active | S |
| Latanoprost 0.005% ophthalmic solution, one drop in each eye at bedtime | One drop in each eye at bedtime | Ophthalmic route | 2000-09-11 | active | S |
| Dorzolamide 2% ophthalmic solution, one drop in each eye twice daily | One drop in each eye twice daily | Ophthalmic route | 2003-02-27 | active | S |
| Midodrine 2.5 mg oral tablet, one tablet by mouth three times daily, last dose by 6 PM | One tablet by mouth on waking, at midday, and mid-afternoon; last dose at least four hours before bed | Oral route | 2003-03-27 to 2003-05-29 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Type 2 diabetes mellitus with diabetic autonomic neuropathy; HbA1c above the individualized goal at intake | active | confirmed | E11.43 | S — Synthetic modern diagnosis linked to the publicly reported diabetes and autonomic neuropathy. |
| Neurogenic orthostatic hypotension from diabetic autonomic neuropathy | active | confirmed | I95.1 | S — Synthetic finding; explains the autonomic symptoms once labeled Shy-Drager syndrome. |
| Diabetic distal symmetric polyneuropathy with loss of protective sensation in both feet | active | confirmed | E11.42 | S — Synthetic finding linked to his description of numb lower extremities. |
| Primary open-angle glaucoma, both eyes, severe stage | active | confirmed | H40.1133 | S — Synthetic modern diagnosis; the type and stage are not documented historically. |
| Mild nonproliferative diabetic retinopathy without macular edema, both eyes | active | confirmed | E11.3293 | S — Synthetic finding from the dilated eye examination. |
| Hyperlipidemia | active | confirmed | E78.5 | S — Synthetic finding from the baseline LDL cholesterol. |
| History of recurrent pneumonia | active | confirmed | Z87.01 | S — Synthetic modern coding of the documented recurrent pneumonia; supports pneumococcal vaccination. |
Vital signs recorded on 2003-03-27; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert and wry; walks in with a cane |
| Cardiovascular | Regular rhythm; blood pressure 150/84 mmHg lying, 142/78 mmHg seated, and 110/68 mmHg after three minutes standing, with heart rate 76 rising only to 80, and lightheadedness |
| Feet | Skin intact; no ulcers or calluses; monofilament and vibration sensation reduced to the ankles; pedal pulses present |
| Neurological | Reduced ankle reflexes; stocking sensory loss in both legs |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2003-03-27 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2003-03-27 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2003-03-27 | Creatinine [Mass/volume] in Serum or Plasma | 1.06 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2003-03-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1998)/1.73 sq M | 72 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2003-03-27 | Glucose [Mass/volume] in Serum or Plasma | 152 | mg/dL | 70-99 mg/dL | High | S |
Data reviewed: The intake HbA1c, kidney function, urine albumin-creatinine ratio, vitamin B12, TSH, and hemoglobin; today's basic metabolic panel; the intake and today's lying, seated, and standing blood pressures and heart rates; and his home glucose log. [S]